-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Avenue Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2020 to Q4 2024.
- Avenue Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending December 31, 2024 was 7.96 USD/shares, a 87.2% decline year-over-year.
- Avenue Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending December 31, 2024 was -15.8 USD/shares, a 78.5% increase year-over-year.
- Avenue Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -15.8 USD/shares, a 78.5% increase from 2023.
- Avenue Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -73.5 USD/shares, a 4408% decline from 2022.
- Avenue Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.63 USD/shares, a 641% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)